biological source
human
Quality Level
recombinant
expressed in E. coli
assay
>95% (SDS-PAGE)
form
solution
mol wt
~31 kDa, apparent mol wt ~27 kDa
shipped in
dry ice
storage temp.
−70°C
Gene Information
human ... PPP1R1A(5502), PPP1R8(5511)
Application
此蛋白磷酸酶抑制剂1适合用作底物，以鉴定调节蛋白磷酸酶抑制剂1活性的新型磷酸酶和激酶。该产品也适用于亲和力敲低结合研究。蛋白磷酸酶抑制剂1人已被用作蔗糖细胞裂解缓冲液中的一种成分。在药理学干预研究中，在腹膜前或腹膜内注射之前，它还被用于对小鼠进行腹膜内注射。
Biochem/physiol Actions
该酶作为磷酸化酶磷酸酶的抑制剂密切参与糖原代谢，负责将磷酸化酶 b转换为磷酸化酶 a。仅在cAMP依赖性蛋白激酶磷酸化时，才会激活抑制作用。
Physical form
以pH 7.0，含 50mM Tris-HCl、0.1 mM PMSF、14 mM 2-巯基乙醇和10％甘油的溶液形式提供
signalword
Warning
hcodes
Hazard Classifications
Skin Sens. 1
存储类别
10 - Combustible liquids
wgk
WGK 3
flash_point_f
Not applicable
flash_point_c
Not applicable
法规信息
常规特殊物品
此项目有
相关内容
Instructions
Inhibition of Inflammatory Changes in Human Myometrial Cells by Cell Penetrating Peptide and Small Molecule Inhibitors of NF kappaB
Gurney LRI, et al.
Frontiers in Immunology, 9, 2966-2966 (2018)
Zlatka Plavec et al.
Viruses, 14(9) (2022-09-24)
Severe acute respiratory syndrome coronavirus-2 is the causative agent of COVID-19. During the pandemic of 2019-2022, at least 500 million have been infected and over 6.3 million people have died from COVID-19. The virus is pleomorphic, and due to its
Xiaonan Liu et al.
Molecular systems biology, 17(11), e10396-e10396 (2021-10-29)
Treatment options for COVID-19, caused by SARS-CoV-2, remain limited. Understanding viral pathogenesis at the molecular level is critical to develop effective therapy. Some recent studies have explored SARS-CoV-2-host interactomes and provided great resources for understanding viral replication. However, host proteins
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| P2745-1UG | 04061838071828 |